A SECRET WEAPON FOR WHO MAKES THE DIABETES DRUG COPYRIGHT

San Diego-dependent Viking Therapeutics marked itself as a serious competitor within the weight loss drug market in February soon after revealing promising data from a mid-stage demo of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when supplied to be a weekly injection and in March the company unveil